Our HLA laboratory in collaboration with the Center for Blood Research provides s large number of genotyped families for all of the known genetic markers of human chromosome 6, including HLA, GLO, and the complotypes (a combination of typing for four different loci encoding for complement proteins C2, Bf, C4A, and C4B). We have developed a large group of serological reagents (antibodies to HLA antigens, alloantibodies, and monoclonal antibodies) to study the complexity of the histocompatibility antigens, in particular, the genetic complexity of the HLA-D/DR region. These reagents will be useful in understanding not only the genetics of the HLA region, but also the biological role of the HLA molecules. In this regard, we have developed a large number of T-cell clones specific for antigen (tetanus toxoid), which proliferate after antigen presentation by macrophages. The antibodies are useful tools in studying the role of HLA-DR in cell-to-cell interaction. We have studied, in a different group of experiments, the phenomenon of linkage disequilibrium or nonrandom association of alleles by examining a large number of families. These studies have permitted us to describe eight extended haplotypes which have been useful in the definition of such diseases as diabetes mellitus (insulin-dependent) and congenital adrenal hyperplasia. One of the haplotypes associated with diabetes (B8, DR3, SCO1, GLO2) is the first human example of a t-murine mutant. These findings will be useful in trying to understand the evolution of humans or the population admixtures (founder effects). We have also used immunoprecipitation by monoclonal antibodies to Class I histocompatibility antigens and isoelectrofocusing to discover variants of known Class I alloantigens encoded by the HLA-B locus. Of interest is the fact that such variants distinguish Caucasians from Orientals. (LB)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA020531-10
Application #
3165319
Study Section
Immunobiology Study Section (IMB)
Project Start
1977-06-01
Project End
1987-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
10
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Yunis, J J; Salazar, M; Delgado, M B et al. (1993) HLA-DQA1, DQB1 and DPB1 alleles on HLA-DQ2- and DQ9-carrying extended haplotypes. Tissue Antigens 41:37-41
Salazar, M; Deulofeut, R; Yunis, J J et al. (1993) A fast PCR-SSP method for HLA-DQ generic typing. Tissue Antigens 41:102-6
Salazar, M; Yunis, I; Alosco, S M et al. (1992) HLA-DPB1 allele mismatches between unrelated HLA-A,B,C,DR (generic) DQA1-identical unrelated individuals with unreactive MLC. Tissue Antigens 39:203-8
Yunis, I; Salazar, M; Alosco, S M et al. (1992) HLA-DQA1 and MLC among HLA (generic)-identical unrelated individuals. Tissue Antigens 39:182-6
Yunis, I; Salazar, M; Yunis, E J (1991) HLA-DR generic typing by AFLP. Tissue Antigens 38:78-88
Fraser, P A; Awdeh, Z L; Ronco, P et al. (1991) C4B gene polymorphisms among African and African-American HLA-Bw42-DRw18 haplotypes. Immunogenetics 34:52-6
Egea, G E; Yunis, I; Spies, T et al. (1991) Association of polymorphisms in the HLA-B region with extended haplotypes. Immunogenetics 33:4-11
Yunis, J J; Wescott, M; Lechin, S J et al. (1990) HLA-DQ RFLP variants of five HLA-DQw2-bearing major histocompatibility complex extended haplotypes. Immunogenetics 32:88-95
Kruskall, M S; Yunis, E J; Watson, A et al. (1990) Major histocompatibility complex markers and red cell antibodies to the Rh (D) antigen. Absence of association. Transfusion 30:15-9
Alper, C A; Kruskall, M S; Marcus-Bagley, D et al. (1989) Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 321:708-12

Showing the most recent 10 out of 34 publications